The Atlantic -- Kayem had sold sodium thiopental to America until this week—when the company’s managing director learned of the anesthetic’s death-row purpose. The controversy over lethal injection as a method of execution escalated today when a pharmaceutical company in India announced that it would no longer supply a crucial drug to death-penalty states.
